Fisher Asset Management, LLC

Position in DNLI — Denali Therapeutics Inc.

CIK 850529 PLANO, TX

Position in DNLI

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$46,788,384

+$4,037,341 QoQ

Shares Held

2,436,895

-5.9% QoQ

Ownership

1.54%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 46.437659398537896.ToString("F0")% Shared 0.ToString("F0")% None 53.56234060146211.ToString("F0")%

Healthcare · as of Mar 31, 2026

Fisher Asset Management, LLC holds $671,245,647 across 48 Biotechnology names. DNLI ranks #4 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	1,113,568	$69,820,713
2	CYTK	Cytokinetics Inc	768,264	$50,636,280
3	RCUS	Arcus Biosciences, Inc.	2,190,404	$47,312,726
4	DNLI	Denali Therapeutics Inc. This page	2,436,895	$46,788,384
5	VRDN	Viridian Therapeutics, Inc.\DE	1,768,295	$34,587,850
6	CLDX	Celldex Therapeutics, Inc.	1,013,648	$32,152,914
7	CGON	CG Oncology, Inc.	465,033	$31,473,433
8	IDYA	IDEAYA Biosciences, Inc.	882,699	$29,411,530

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$46,788,384	2,436,895	-5.9%	Shares	Defined	2026-05-05
2025-12-31	$42,751,043	2,589,403	+58.7%	Shares	Defined	2026-02-09
2025-09-30	$23,689,321	1,631,496	+7.6%	Shares	Defined	2025-11-12
2025-06-30	$21,208,714	1,515,991	+11.1%	Shares	Defined	2025-08-13
2025-03-31	$18,556,617	1,364,959	+72.2%	Shares	Defined	2025-05-14
2024-12-31	$16,151,129	792,499	+44.8%	Shares	Defined	2025-02-05
2024-09-30	$15,943,752	547,331	+14.5%	Shares	Defined	2024-11-12
2024-06-30	$11,101,667	478,108	+1.9%	Shares	Defined	2024-08-14
2024-03-31	$9,627,347	469,169	—	Shares	Defined	2024-05-09
No filing history on record for this holder in this stock.